NeuroPace, Inc. (NPCE)
NASDAQ: NPCE · Real-Time Price · USD
11.53
+0.39 (3.50%)
Dec 20, 2024, 4:00 PM EST - Market closed
NeuroPace Employees
NeuroPace had 171 employees as of December 31, 2023. The number of employees increased by 4 or 2.40% compared to the previous year.
Employees
171
Change (1Y)
4
Growth (1Y)
2.40%
Revenue / Employee
$447,088
Profits / Employee
-$164,275
Market Cap
344.15M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 171 | 4 | 2.40% |
| Dec 31, 2022 | 167 | 1 | 0.60% |
| Dec 31, 2021 | 166 | 14 | 9.21% |
| Dec 31, 2020 | 152 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Revance Therapeutics | 597 |
| Spok Holdings | 384 |
| AirSculpt Technologies | 381 |
| Olema Pharmaceuticals | 74 |
| Jasper Therapeutics | 45 |
| Contineum Therapeutics | 31 |
| Eton Pharmaceuticals | 30 |
| Corvus Pharmaceuticals | 28 |
NPCE News
- 3 days ago - NeuroPace to Present at the 43rd Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 9 days ago - NeuroPace to Host Investor Day on January 28th in New York City - GlobeNewsWire
- 17 days ago - NeuroPace to Showcase the RNS System at the 2024 American Epilepsy Society (AES) Annual Meeting - GlobeNewsWire
- 18 days ago - NeuroPace Completes Enrollment in Feasibility Study of RNS System for Lennox-Gastaut Syndrome - GlobeNewsWire
- 5 weeks ago - NeuroPace, Inc. (NPCE) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - NeuroPace Announces FDA Submission of Three-Year Data from Post-Approval Study of the RNS System in Focal Epilepsy - GlobeNewsWire
- 2 months ago - NeuroPace to Report Third Quarter 2024 Financial Results on November 12, 2024 - GlobeNewsWire
- 2 months ago - NeuroPace Continues to Strengthen Management Team - GlobeNewsWire